AIM2 and neurodegenerative disease: Targeting of AIM2 signaling pathways presents a promising therapeutic avenue for neuroprotection in neurodegenerative diseases, with various strategies focusing on regulating AIM2 expression, activation, and downstream signaling pathways (Figure 3).